132 related articles for article (PubMed ID: 26560137)
1. Moving toward the ideal insulin for insulin pumps.
Cengiz E; Bode B; Van Name M; Tamborlane WV
Expert Rev Med Devices; 2016; 13(1):57-69. PubMed ID: 26560137
[TBL] [Abstract][Full Text] [Related]
2. Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidase.
Muchmore DB; Vaughn DE
J Diabetes Sci Technol; 2012 Jul; 6(4):764-72. PubMed ID: 22920800
[TBL] [Abstract][Full Text] [Related]
3. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
4. [Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment].
Hamaguchi T; Sadahiro K; Satoh T
Nihon Rinsho; 2015 Mar; 73(3):447-52. PubMed ID: 25812371
[TBL] [Abstract][Full Text] [Related]
5. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
[TBL] [Abstract][Full Text] [Related]
6. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
7. [New developments in the treatment and monitoring of type 1 diabetes mellitus].
Otto-Buczkowska E; Jarosz-Chobot P; Tucholski K
Endokrynol Pol; 2008; 59(3):246-53. PubMed ID: 18615401
[TBL] [Abstract][Full Text] [Related]
8. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
9. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
Catargi B; Breilh D; Roger P; Tabarin A
Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
[TBL] [Abstract][Full Text] [Related]
10. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
Pfützner A; Berger S; Spinas G
Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
[TBL] [Abstract][Full Text] [Related]
11. Closed-loop system in the management of diabetes: past, present, and future.
Shah VN; Shoskes A; Tawfik B; Garg SK
Diabetes Technol Ther; 2014 Aug; 16(8):477-90. PubMed ID: 25072271
[TBL] [Abstract][Full Text] [Related]
12. Increasing local blood flow by warming the application site: beneficial effects on postprandial glycemic excursions.
Freckmann G; Pleus S; Haug C; Bitton G; Nagar R
J Diabetes Sci Technol; 2012 Jul; 6(4):780-5. PubMed ID: 22920802
[TBL] [Abstract][Full Text] [Related]
13. Insulin pump therapy (continuous subcutaneous insulin infusion).
White RD
Prim Care; 2007 Dec; 34(4):845-71, vii. PubMed ID: 18061820
[TBL] [Abstract][Full Text] [Related]
14. Emerging diabetes therapies and technologies.
Moser EG; Morris AA; Garg SK
Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
[TBL] [Abstract][Full Text] [Related]
15. Continuous glucose monitoring and insulin pump therapy for diabetes in pregnancy.
Combs CA
J Matern Fetal Neonatal Med; 2012 Oct; 25(10):2025-7. PubMed ID: 22384837
[TBL] [Abstract][Full Text] [Related]
16. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
Potti LG; Haines ST
J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
[TBL] [Abstract][Full Text] [Related]
17. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
[TBL] [Abstract][Full Text] [Related]
18. The pathway to the closed-loop artificial pancreas: research and commercial perspectives.
Keenan DB; Cartaya R; Mastrototaro JJ
Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():445-51. PubMed ID: 20877259
[TBL] [Abstract][Full Text] [Related]
19. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
20. Insulin pump therapy in adults.
Didangelos T; Iliadis F
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
